Pharmaceuticals, Biotechnology and Life Sciences
Unique PD-L1-mediated immune changes and early signs of anti-tumor activity with MT-6402 Continued dose-finding with MT-5111 and MT-0169 Pipeline advancing…
MELBOURNE, Australia and PORTO ALEGRE, Brazil, Nov. 30, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company)…
TUSTIN, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization…
New trial is in collaboration with Japan’s National Center for Geriatrics and Gerontology (NCGG) and Juntendo University HospitalMIAMI, Nov. 30,…
Company announcement – No. 73 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021 Copenhagen, DK and Boston,…
COURT SANCTIONS THE SCHEME OF ARRANGEMENTLONDON, Nov. 30, 2021 (GLOBE NEWSWIRE) — Reference is made to the terms of a…
EUROBIO SCIENTIFIC LAUNCHES THE FIRST PCR TEST ALLOWING SIMULTANEOUS SARS-COV-2 VIRUS SCREENING AND DETECTION OF THE DELTA AND OMICRON VARIANTS…
Company announcement no. 23 – 2130 November 2021 NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA. THE…
Company announcement – No. 72 / 2021 Total number of shares and voting rights in Zealand Pharma at November 30, 2021…
Company to form majority owned subsidiary, 3CL Sciences, an entity focused on the development of variant-agnostic COVID-19 antivirals such as…